SCUBA

HCAR2 — Hydroxycarboxylic acid receptor 2

HCAR2 belongs to a gene co-expression module in 3 of 28 SCUBA cell types. Each module groups genes that rise and fall together in that cell type; the genes it shares a module with are its closest co-expression partners there.

HCAR2's module in each cell type

Cell typeModuleShares the module with
FibroblastsBMP-ID Stress Response
Stress
BHLHE40, CCDC184, CFAP20, FOXC2, GADD45G, GDF15, GDNF, HAS1 +9 moreView in SCUBA
MacrophagesEfferocytosis Anti-inflammatory
Lysosomal & pahgocytosis
ABHD12, ADGRG5, AIG1, AXL, CCS, CD101, CD1D, CD300A +18 moreView in SCUBA
NeutrophilsChemokine Secretion
Cytokine & chemokine secretion
CXCL1, CXCL2, CXCL8, DDIT3, GADD45B, GLUL, IER5, MAFF +3 more

About the gene

SynonymsGPR109A, HCA2, HM74A, NIACR1, Puma-g, PUMAG
Chromosome12: 122701293-122703357
Predicted locationMembrane
Essential geneNo
Protein classFDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins
Molecular functionG-protein coupled receptor, Receptor, Transducer
Biological processApoptosis

Function

Acts as a high affinity receptor for both nicotinic acid (also known as niacin) and (D)-beta-hydroxybutyrate and mediates increased adiponectin secretion and decreased lipolysis through G(i)- protein-mediated inhibition of adenylyl cyclase. This pharmacological effect requires nicotinic acid doses that are much higher than those provided by a normal diet. Mediates nicotinic acid-induced apoptosis in mature neutrophils. Receptor activation by nicotinic acid results in reduced cAMP levels which may affect activity of cAMP-dependent protein kinase A and phosphorylation of target proteins, leading to neutrophil apoptosis. The rank order of potency for the displacement of nicotinic acid binding is 5-methyl pyrazole-3-carboxylic acid = pyridine-3-acetic acid > acifran > 5-methyl nicotinic acid = acipimox >> nicotinuric acid = nicotinamide

Human Protein Atlas · Open Targets · UniProt

Gene annotation from the Human Protein Atlas and UniProt; see sources & licences.